Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

Adra, Nabil; Albany, Costantine; Brames, Mary J; Case-Eads, Somer; Johnson, Cynthia S; Liu, Ziyue; Fausel, Christopher A; Breen, Timothy; Hanna, Nasser H; Hauke, Ralph J; Picus, Joel; Einhorn, Lawrence H

Adra, Nabil; Albany, Costantine; Brames, Mary J; Case-Eads, Somer; Johnson, Cynthia S; Liu, Ziyue; Fausel, Christopher A; Breen, Timothy; Hanna, Nasser H; Hauke, Ralph J; Picus, Joel; Einhorn, Lawrence H.

Afiliação

Adra N; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA. nadra@iu.edu.
Albany C; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.
Brames MJ; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.
Case-Eads S; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.
Johnson CS; Department of Biostatistics, Indiana University, Indianapolis, IN, USA.
Liu Z; Department of Biostatistics, Indiana University, Indianapolis, IN, USA.
Fausel CA; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.
Breen T; Hoosier Cancer Research Network, Indianapolis, IN, USA.
Hanna NH; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.
Hauke RJ; Methodist Hospital/Nebraska Cancer Specialists, Omaha, NE, USA.
Picus J; Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Einhorn LH; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.

Support Care Cancer ; 24(7): 2837-42, 2016 07.

Article em En | MEDLINE | ID: mdl-26838019

Assuntos

Cisplatino/uso terapêutico; Dexametasona/uso terapêutico; Morfolinas/uso terapêutico; Neoplasias Embrionárias de Células Germinativas/tratamento farmacológico; Antagonistas do Receptor 5-HT3 de Serotonina/uso terapêutico; Adolescente; Adulto; Idoso; Cisplatino/administração & dosagem; Cisplatino/farmacologia; Dexametasona/administração & dosagem; Dexametasona/farmacologia; Quimioterapia Combinada; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Morfolinas/administração & dosagem; Morfolinas/farmacologia; Neoplasias Embrionárias de Células Germinativas/patologia; Antagonistas do Receptor 5-HT3 de Serotonina/administração & dosagem; Antagonistas do Receptor 5-HT3 de Serotonina/farmacologia; Adulto Jovem

Palavras-chave

Chemotherapy-induced nausea and vomiting; Fosaprepitant; Germ cell tumor; Testicular cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Morfolinas / Cisplatino / Neoplasias Embrionárias de Células Germinativas / Antagonistas do Receptor 5-HT3 de Serotonina Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google